Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Quick Stats
Jan 30, 202644.8
AI Score
HOLD1.53
Volume Ratio
Mar 12, 2026
Next Earnings
8
+ve Days (30d)
21
-ve Days (30d)
QNRX Stock Summary
Last updated Jan 30, 2026
QNRX is currently trading at $7.215, positioned below its 200-day moving average of $9.98, suggesting bearish momentum. The stock has a 52-week range of $5.01 to $41.8.
Technical Analysis: The 50-day moving average stands at $13.86, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 22.406, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.467, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates QNRX at 44.8/100 with a HOLD recommendation.
QNRX (Quoin Pharmaceuticals, Ltd. American Depositary Shares) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 22.406 |
| CMF (20) | -0.467 |
| ROC (10) | -32.317 |
| ADX (14) | 31.724 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.387 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -95.869 |
| MFI (14) | 10.229 |
QNRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
QNRX Price vs Max Options Open Interest
QNRX Max Change In Options Open Interest
QNRX Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNRX Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNRX Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
QNRX Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Quoin Pharmaceuticals, Ltd. American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
QNRX Moving Averages Analysis
QNRX (Quoin Pharmaceuticals, Ltd. American Depositary Shares) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 9.36 |
| 20 | 10.97 |
| 30 | 11.99 |
| 50 | 13.86 |
| 100 | 12.16 |
| 200 | 9.98 |
QNRX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 14.7 million |
| Earnings/Share ($) | -29.17 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -11.6 |
| EPS Estimate Next Year ($) | -5.55 |
| WallStreet Target Price ($) | 40.6667 |
| Most Recent Quarter |